• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择性 5-羟色胺再摄取抑制剂(SSRIs)类抗抑郁药戒断的真实体验:一项定性访谈研究。

The lived experience of withdrawal from Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants: A qualitative interview study.

机构信息

Department of Psychology, University of Bath, Bath, UK.

Bristol Medical School, Centre for Academic Mental Health, Population Health Sciences, University of Bristol, Bristol, UK.

出版信息

Health Expect. 2024 Feb;27(1):e13966. doi: 10.1111/hex.13966.

DOI:10.1111/hex.13966
PMID:39102706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10774987/
Abstract

BACKGROUND

Our knowledge of the broader impacts of antidepressant withdrawal, beyond physical side effects, is limited. Further research is needed to investigate the lived experiences of withdrawal, to aid clinicians on how to guide patients through the process.

AIM

To explore antidepressant users' experiences and views on the withdrawal process and how it affected their quality of life across multiple life domains.

DESIGN AND SETTING

We conducted in-depth qualitative interviews with 20 individuals from the community who had attempted to withdraw from Serotonin Reuptake Inhibitor antidepressants in the past year.

METHOD

Semi-structured interviews were conducted online. A topic guide was used to ensure consistency across interviews. The interviews were audio-recorded and transcribed verbatim and analysed using inductive reflexive thematic analysis.

RESULTS

Five themes were generated. The first highlighted the challenges of managing the release from emotional blunting and cognitive suppression following antidepressant discontinuation. The second related to the negative impact of withdrawal on close relationships and social interactions. The third showed that concurrent with negative physical symptoms, there was a positive impact on health (exercise was reported by some as a coping mechanism). The fourth theme focused on support from GPs and families, emphasising the importance of mental health literacy in others. The final theme underscored the importance of gradual and flexible tapering in enabling a manageable withdrawal experience, and the consideration of timing.

CONCLUSION

The lived experience of withdrawal significantly impacts individuals' well-being. Participants emphasised that withdrawal is not just about physical side effects but also affects their emotional, cognitive, and social functioning.

PATIENT AND PUBLIC INVOLVEMENT (PPI): Eight people attended individual online meetings to share their experiences of antidepressant withdrawal to help inform the study design and recruitment strategy. Insights from these meetings informed the development of the topic guide. Questions about GP involvement, family relationships, and mood and thinking changes were included based on this PPI work. This ensured the inclusion of topics important to antidepressant users and facilitated the researcher's questioning during the interviews.

摘要

背景

我们对抗抑郁药戒断除了身体副作用之外的更广泛影响知之甚少。需要进一步研究来调查戒断的真实体验,以帮助临床医生指导患者度过这一过程。

目的

探索抗抑郁药使用者对戒断过程的体验和看法,以及戒断过程如何影响他们在多个生活领域的生活质量。

设计和环境

我们对过去一年中试图停止使用选择性 5-羟色胺再摄取抑制剂类抗抑郁药的 20 名社区居民进行了深入的定性访谈。

方法

在线进行半结构化访谈。使用主题指南来确保访谈的一致性。访谈进行了录音,并逐字转录,采用归纳性反思主题分析方法进行分析。

结果

生成了五个主题。第一个主题强调了在停止使用抗抑郁药后,从情绪麻木和认知抑制中恢复所面临的挑战。第二个主题涉及戒断对亲密关系和社交互动的负面影响。第三个主题表明,与负面身体症状同时出现的是对健康的积极影响(一些人报告说锻炼是一种应对机制)。第四个主题侧重于全科医生和家庭的支持,强调了他人心理健康素养的重要性。最后一个主题强调了逐渐和灵活地逐渐减少剂量以使戒断过程更易于管理,并考虑时机的重要性。

结论

戒断的真实体验会对个人的幸福感产生重大影响。参与者强调,戒断不仅仅是身体副作用的问题,还会影响他们的情绪、认知和社交功能。

患者和公众参与(PPI):八人参加了单独的在线会议,分享他们对抗抑郁药戒断的体验,以帮助确定研究设计和招募策略。从这些会议中获得的见解为主题指南的制定提供了信息。根据这项 PPI 工作,包括了有关全科医生参与、家庭关系以及情绪和思维变化的问题。这确保了纳入了抗抑郁药使用者重要的主题,并促进了研究人员在访谈中的提问。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ab/10774987/9832a4a24ab3/HEX-27-e13966-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ab/10774987/9832a4a24ab3/HEX-27-e13966-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ab/10774987/9832a4a24ab3/HEX-27-e13966-g001.jpg

相似文献

1
The lived experience of withdrawal from Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants: A qualitative interview study.选择性 5-羟色胺再摄取抑制剂(SSRIs)类抗抑郁药戒断的真实体验:一项定性访谈研究。
Health Expect. 2024 Feb;27(1):e13966. doi: 10.1111/hex.13966.
2
Antidepressants for people with epilepsy and depression.用于癫痫伴抑郁症患者的抗抑郁药。
Cochrane Database Syst Rev. 2014 Dec 3;2014(12):CD010682. doi: 10.1002/14651858.CD010682.pub2.
3
Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.联合米氮平与 SSRIs 或 SNRIs 治疗难治性抑郁症:MIR RCT。
Health Technol Assess. 2018 Nov;22(63):1-136. doi: 10.3310/hta22630.
4
Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.成人抑郁和焦虑障碍中长效抗抑郁药停药与继续使用的方法。
Cochrane Database Syst Rev. 2021 Apr 15;4(4):CD013495. doi: 10.1002/14651858.CD013495.pub2.
5
'Doing the right thing': factors influencing GP prescribing of antidepressants and prescribed doses.“做正确的事”:影响全科医生开具抗抑郁药及处方剂量的因素
BMC Fam Pract. 2017 Jun 17;18(1):72. doi: 10.1186/s12875-017-0643-z.
6
Antidepressants for people with epilepsy and depression.抗抑郁药治疗癫痫合并抑郁患者。
Cochrane Database Syst Rev. 2021 Apr 16;4(4):CD010682. doi: 10.1002/14651858.CD010682.pub3.
7
Qualitative Study定性研究
8
Better safe than sorry--why patients prefer to stop using selective serotonin reuptake inhibitor (SSRI) antidepressants but are afraid to do so: results of a qualitative study.宁可安全无虞,不可追悔莫及——患者为何更倾向于停用选择性5-羟色胺再摄取抑制剂(SSRI)类抗抑郁药却又心存顾虑:一项定性研究的结果
Chronic Illn. 2006 Jun;2(2):133-42. doi: 10.1177/17423953060020020801.
9
Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial.米氮平联合选择性5-羟色胺再摄取抑制剂用于基层医疗中难治性抑郁症的治疗(MIR试验):一项随机对照试验的研究方案
Trials. 2016 Feb 3;17:66. doi: 10.1186/s13063-016-1199-2.
10
A qualitative study of patient views on discontinuing long-term selective serotonin reuptake inhibitors.一项关于患者对停用长期选择性5-羟色胺再摄取抑制剂看法的定性研究。
Fam Pract. 2007 Dec;24(6):570-5. doi: 10.1093/fampra/cmm069. Epub 2007 Nov 20.

引用本文的文献

1
'I Wish It Were More Often Told to People Before They Are Prescribed These Medications How Hard It Is to Get Off Them': A Qualitative Descriptive Analysis of Free-Text Responses to a Survey on Reducing and Stopping Psychiatric Medication.“我希望在给人们开这些药之前,能更经常地告诉他们停药有多难”:对一项关于减少和停用精神科药物的调查的自由文本回复的定性描述性分析
Health Expect. 2025 Aug;28(4):e70384. doi: 10.1111/hex.70384.
2
Learning Latent Profiles via Cognitive Growth Charting in Psychosis: Design and Rationale for the PRECOGNITION Project.通过精神病认知成长图表学习潜在特征:PRECOGNITION项目的设计与原理
Schizophr Bull Open. 2025 Apr 9;6(1):sgaf007. doi: 10.1093/schizbullopen/sgaf007. eCollection 2025 Jan.
3

本文引用的文献

1
The need for antidepressant withdrawal support services: Recommendations from 708 patients.对抗抑郁药戒断支持服务的需求:708名患者的建议
Psychiatry Res. 2023 Aug;326:115303. doi: 10.1016/j.psychres.2023.115303. Epub 2023 Jun 22.
2
Designing withdrawal support services for antidepressant users: Patients' views on existing services and what they really need.为抗抑郁药使用者设计戒断支持服务:患者对现有服务的看法及他们真正的需求。
J Psychiatr Res. 2023 May;161:298-306. doi: 10.1016/j.jpsychires.2023.03.013. Epub 2023 Mar 20.
3
Exercise as medicine for depressive symptoms? A systematic review and meta-analysis with meta-regression.
A systematic review of manipulations to pharmaceutical dosage forms used in psychotropic tapering plans.
对用于精神药物减药计划的药物剂型操作的系统评价。
Br J Clin Pharmacol. 2025 Jul;91(7):1899-1913. doi: 10.1002/bcp.70082. Epub 2025 Apr 27.
4
Rebound effect, discontinuation, and withdrawal syndromes associated with drugs used in psychiatric and neurological disorders.与精神和神经疾病用药相关的反跳效应、停药反应及戒断综合征。
Pharmacol Rep. 2025 Apr;77(2):303-314. doi: 10.1007/s43440-024-00689-z. Epub 2024 Dec 23.
运动作为治疗抑郁症状的药物?系统评价和荟萃分析及荟萃回归。
Br J Sports Med. 2023 Aug;57(16):1049-1057. doi: 10.1136/bjsports-2022-106282. Epub 2023 Feb 1.
4
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data.评估从已发表数据综述中得出的抗抑郁药撤药风险。
CNS Drugs. 2023 Feb;37(2):143-157. doi: 10.1007/s40263-022-00960-y. Epub 2022 Dec 14.
5
Comparative effectiveness of exercise, antidepressants and their combination in treating non-severe depression: a systematic review and network meta-analysis of randomised controlled trials.运动、抗抑郁药及其联合治疗非重度抑郁症的疗效比较:随机对照试验的系统评价和网络荟萃分析。
Br J Sports Med. 2022 Dec;56(23):1375-1380. doi: 10.1136/bjsports-2022-105964. Epub 2022 Sep 16.
6
Emotional blunting in patients with depression. Part I: clinical characteristics.抑郁症患者的情感迟钝。第一部分:临床特征。
Ann Gen Psychiatry. 2022 Apr 4;21(1):10. doi: 10.1186/s12991-022-00387-1.
7
Should I, can I, dare I? Patients' view on stopping long-term antidepressant use, a qualitative study.我应该吗?我能够吗?我敢吗?患者对停止长期使用抗抑郁药的看法,一项定性研究。
Acta Clin Belg. 2022 Dec;77(6):962-969. doi: 10.1080/17843286.2021.2024384. Epub 2022 Jan 10.
8
The Effects and Mechanisms of Exercise on the Treatment of Depression.运动对抑郁症治疗的作用及机制
Front Psychiatry. 2021 Nov 5;12:705559. doi: 10.3389/fpsyt.2021.705559. eCollection 2021.
9
Maintenance or Discontinuation of Antidepressants in Primary Care.在初级保健中维持或停止使用抗抑郁药。
N Engl J Med. 2021 Sep 30;385(14):1257-1267. doi: 10.1056/NEJMoa2106356.
10
Long-term antidepressant use in general practice: a qualitative study of GPs' views on discontinuation.全科医生中抗抑郁药物的长期使用:关于停药的定性研究。
Br J Gen Pract. 2021 Jun 24;71(708):e508-e516. doi: 10.3399/BJGP.2020.0913. Print 2021 Jul.